CDIB BioScience Ventures

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 17
Average round size
info
The average size of a deal this fund participated in
$35M
Portfolio companies 14
Rounds per year 0.81
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.18
Exits 9
Key employees 1
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Health Care
  • Therapeutics
Summary

In 2001 was created CDIB BioScience Ventures, which is appeared as VC. The company was established in North America in United States. The main office of represented VC is situated in the San Diego.

Speaking about the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2008. The average startup value when the investment from CDIB BioScience Ventures is 10-50 millions dollars. The important activity for fund was in 2006. Opposing the other organizations, this CDIB BioScience Ventures works on 17 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Accelight Networks, Elixir Pharmaceuticals, Epiphany. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Biotechnology, Therapeutics.

The overall number of key employees were 1.

The typical case for the fund is to invest in rounds with 7-8 participants. Despite the CDIB BioScience Ventures, startups are often financed by Venrock, ARCH Venture Partners, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are Venrock, Montreux Equity Partners, Domain Associates. In the next rounds fund is usually obtained by Venrock, MPM Capital, ARCH Venture Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CDIB BioScience Ventures:
Typical Co-investors
CDIB BioScience Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CDIB BioScience Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Government of Karnataka - Elevate 2018 -
Guangrun Chuangtou China, Hangzhou, Zhejiang
JHD -
Lakeside Capital Dallas, Texas, United States
Lightyear Capital Beijing, Beijing, China
LT Invest. -
Muyi Touzi China, Shanghai
Novitas Capital Pennsylvania, United States, Wayne
Park City Angels Park City, United States, Utah
PCG Holdings -
Rifkin-Pottle Group -
Shenzhenshi Tianhe Tongxin Touzi China, Guangdong, Shenzhen
Summation Health Ventures California, Long Beach, United States
Total France, Ile-de-France, Paris
Tristone Capital Houston, Texas, United States
WeltN24 Berlin, Berlin, Germany
Western Ontario Cummunity Futures Development Corporation Association (WOCFDCA) -
WLR China Energy Infrastructure Fund -
Yuechan Guquan China, Foshan, Guangdong

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ConforMIS

Health Care
Medical Device
Therapeutics
$14M09 Jul 2008 Massachusetts, United States

Ocera Therapeutics

Biopharma
Biotechnology
Therapeutics
$35M20 Feb 2008 Palo Alto, California, United States

Epiphany

Biotechnology
Health Diagnostics
Therapeutics
$36M16 Mar 2007 San Francisco, California, United States

Proprius Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$11M08 Jan 2007 San Diego, California, United States

Aprima Medical Software

Health Care
Medical
Medical Device
Software
$6M28 Dec 2006 Texas, United States

Xanthus Pharmaceuticals

Biopharma
Biotechnology
Medical
Pharmaceutical
$25M01 Dec 2006 Cambridge, Massachusetts, United States

Elixir Pharmaceuticals

Biotechnology
Diabetes
Pharmaceutical
$31M27 Nov 2006 Cambridge, Massachusetts, United States

Nanosys

Advanced Materials
Computer
Consumer Electronics
Electronics
Manufacturing
Nanotechnology
TV
$41M09 Nov 2005 Milpitas, California, United States

Cerexa Inc.

Biotechnology
Health Care
Medical
Pharmaceutical
$50M23 Aug 2005 New York, New York, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CDIB BioScience Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: